Members of the Board of Directors are organizational stewards who are passionate about endocrine research and practice and are committed to our mission – to unite, lead, and grow the endocrine community to accelerate scientific breakthroughs and improve health worldwide. To learn more about this dynamic group of leaders, please review their bios. If you’d like to become a member leader, learn more today.
President
Gary D. Hammer, MD, PhD
University of Michigan
Term end: 2022
President-elect
Carol H. Wysham, MD
Rockwood Clinic
Term end: 2023
Immediate Past President
E. Dale Abel, MD, PhD
University of Iowa
Term end: 2021
Secretary/Treasurer
Dolores M. Shoback, MD
University of California, San Francisco
Term end: 2022
Henry Anhalt, DO
Science37
Private Practice
Term end: 2021
Richard J. Auchus, MD, PhD
University of Michigan
Term end: 2023
Samantha Butts, MD
Penn State Health/Hershey Medical Center
Term end: 2022
Ann Danoff, MD
CMCVAMC & Perelman School of Medicine
Term end: 2021
Ghada El-Hajj Fuleihan, MD, MPH
American University of Beirut
Term end: 2022
Whitney Goldner, MD
University of Nebraska Medical Center
Term end: 2022
Ruth Keri, PhD
Cleveland Clinic
Term end: 2023
Kathryn A. Martin, MD
Harvard University Medical School
Term end: 2023
John Newell-Price, MD, PhD, FRCP
University of Sheffield
Term end: 2023
Stephen M. Rosenthal, MD
University of California, San Francisco
Term end: 2021
Joy Wu, MD, PhD
Stanford University
Term end: 2022
Ex-Officio, Early Career Director
Lindsey Treviño, PhD
City of Hope
Term end: 2023
Ex-Officio, Nominating Committee Chair
Jenny Visser, PhD
Erasmus MC, Rotterdam
Term end: 2021
Secure the most competitive pricing for ENDO by taking advantage of our Early Registration rates, available now for a limited time!
Join us as we plan for the future by renewing today! Renewing your membership is the best way to ensure that you remain a key part of our efforts to support the global endocrine community.
